Skip to main content
OpenTrials
Completed

NCT Number: NCT04787510

COVID-19 Disease and Coagulopathy: Assessment of Clotting Factor Levels in Patients With SARS-CoV-2 Infection

Effect of Covid-19 disease in clotting factors levels in hospitalized patients

Completed

Looking for future studies?

Notify Me

Key information

Conditions

SARS-CoV2 Infection COVID-19 COVID-19 Disease Coronaviridae Infections Coronavirus Infections Hospitalized Patients Infections Lung Diseases Nidovirales Infections Pneumonia Pneumonia, Viral RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Virus Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

University General Hospital of Ioannina

Ioannina, Epirus, 45500, Greece

About this study

Effect of Covid-19 disease in clotting factors levels in hospitalized patients positive for sars-cov2 infection.

Association between clotting factors levels and disease severity,morbidity and mortality in these patients.

Effect of anticoagulant therapy in the clotting factors' levels in these patients

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • AGE> 18
  • SINGED INFORMED CONSENT FORM
  • POSITIVE PCR TEST FOR SARS-COV2 INFECTION
  • FINDINGS IN CXR OR CT OF THE LUNGS CONSISTENT WITH INFECTION OF LOWER RESPIRATORY TRACT

Exclusion criteria

  • AGE<18
  • DENIAL TO PROVIDE INFORMED CONSENT FORM
  • HISTORY OF MALIGNANCY
  • PRIOR USE OF ANTICOAGULANT THERAPY
  • PRIOR USE OF STEROIDS LONGER THAN 14 DAYS
  • LACTATION-PREGNANCY

Treatment and study plan

low molecular weight Heparin as standard of care treatment

Drug

STANDARD OF CARE

Primary outcomes

  1. EFFECT OF COVID-19 DISEASE IN CLOTTING FACTORS

    Time frame: 6 MONTHS

    leves of cloting factors before and after treatment with LMWH

Sponsors and collaborators

Lead sponsor

University Hospital, Ioannina

Other

Collaborators

  • INTERNAL MEDICINE DEPARTMENT, 1ST WARD

Registry information

Important dates

Study start
2020
Primary completion
2021
Study completion
2021
First posted
Mar 8, 2021
Registry last updated
Sep 28, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.